Kubota Pharmaceutical : Summary of Financial Results for the second quarter 2021

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

August 12, 2021

Consolidated Financial Results

for the Six Months Ended June 30, 2021

(under IFRS)

Company name:	Kubota Pharmaceutical Holdings Co., Ltd.
Listing:	Tokyo Stock Exchange
Securities code:	4596
URL:	https://www.kubotaholdings.co.jp/en/
Representative:	Ryo Kubota, Representative Executive Officer, Chairman, President and Chief
	Executive Officer
Inquiries:	Yumiko Hamanaka, Head of Corporate Planning Division
Telephone:	[phone]

Scheduled date of the submission of quarterly securities report:	August 12, 2021
Scheduled date to commence dividend payments:	-
Preparation of supplementary material on quarterly financial results:	Yes
Holding of quarterly financial results presentation meeting:	Yes (for institutional investors and analysts)

(Yen amounts are rounded to the nearest million, unless otherwise noted.)

1. Consolidated financial results for the six months ended June 30, 2021 (January 1, 2021 to June 30, 2021)

(1) Consolidated operating results (cumulative)	(Percentages indicate year-on-year changes.)
		Revenue				Operating profit		Profit before tax		Net profit
Six months ended	Millions of yen		%		Millions of yen		%		Millions of yen	%		Millions of yen	%
June 30, 2021		-		-			(1,335)		-		(1,351)	-		(1,351)	-
June 30, 2020	38		-			(1,292)		-		(1,253)	-		(1,253)	-
	Profit attributable to		Total comprehensive		Basic earnings per		Diluted earnings per
	owners of parent			income			share			share
Six months ended	Millions of yen		%		Millions of yen		%			Yen			Yen
June 30, 2021	(1,351)		-			(1,077)		-			(29.86)			(29.86)
June 30, 2020	(1,253)		-			(1,363)		-			(29.64)			(29.64)
(2) Consolidated financial position
							Total shareholders'	Equity attributable to	Ratio of equity
		Total assets		attributable to owners
							equity			owners of parent	of parent
As of		Millions of yen	Millions of yen	Millions of yen		%
June 30, 2021				5,874				5,215		5,215			88.8
December 31, 2020				6,692				5,993		5,993			89.6

2. Cash dividends

			Annual dividends per share
	First		Second	Third		Fiscal		Total
	quarter-end		quarter-end	quarter-end		year-end
	Yen		Yen	Yen		Yen		Yen
Fiscal year ended December 31,	-	0.00	-		0.00	0.00
2020
Fiscal year ending December 31,	-	0.00
2021
Fiscal year ending December 31,				-		0.00	0.00
2021 (Forecast)
(Note) Revisions to the forecast of cash dividends most recently announced: None

3. Consolidated earnings forecasts for the fiscal year ending December 31, 2021 (January 1, 2021 to December 31, 2021)

(Percentages indicate year-on-year changes.)

	Revenue			Operating profit	Profit before tax	Net profit
Full year	Millions of yen			%		Millions of yen	%	Millions of yen	%	Millions of yen		%
10			(73.5)		(2,900)	-	(2,800)	-	(2,800)		-
	Profit attributable to		Basic earnings per
	owners of parent		share
Full year	Millions of yen			%			Yen
(2,800)			-			(62.84)

(Note) Revisions to the earnings forecasts most recently announced: None

* Notes

1. Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting in the change in scope of consolidation): None
   Newly included: None
   Excluded: None
2. Changes in accounting policies and changes in accounting estimates
3. 1. Changes in accounting policies required by IFRS: None
   2. Changes in accounting policies due to other reasons: None
   3. Changes in accounting estimates: None
4. Number of issued shares (ordinary shares)
5. 1. Total number of issued shares at end of the period (including treasury shares)

As of June 30, 2021	45,516,388 shares
As of December 31, 2020	44,558,588 shares

(ii) Number of treasury shares at end of the period

As of June 30, 2021	70 shares
As of December 31, 2020	70 shares

1. Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)

For the six months ended June 30, 2021	45,242,597 shares
For the six months ended June 30, 2020	42,295,790 shares

• Quarterly financial results reports are exempt from quarterly reviews conducted by certified public accountants or an audit corporation.
• Proper use of earnings forecasts, and other special items (Cautions on forward-looking statements, etc.)
  The earnings forecasts and other forward-looking statements contained in these materials are based on information currently available to Kubota Pharmaceutical Holdings Co., Ltd. (the "Company") and on certain assumptions deemed to be reasonable by the Company. Actual business performance and other results may differ substantially due to various factors. Please refer to "1. Qualitative Information Regarding Financial Results for the Six Months ended June 30, 2021, (3) Explanation of consolidated earnings forecasts and other forward-looking statements" on page 4 of the attached materials for matters relating to earnings forecasts.
  (Means of obtaining the presentation material on quarterly financial statements)
  The Company is planning to hold a quarterly financial results presentation meeting (WEB conference, in Japanese only, recorded and available on the Company's website at a later date) for institutional investors and analysts on August 24, 2021.
  The Company also plans to post presentation materials (in English and Japanese) for the quarterly financial results and the recorded WEB conference available on the Company's website.